These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21632271)

  • 21. Identification of three novel LRRK2 mutations associated with Parkinson's disease in a Calabrian population.
    Anfossi M; Colao R; Gallo M; Bernardi L; Conidi ME; Frangipane F; Vasso F; Puccio G; Clodomiro A; Mirabelli M; Curcio SA; Torchia G; Smirne N; Di Lorenzo R; Maletta R; Bruni AC
    J Alzheimers Dis; 2014; 38(2):351-7. PubMed ID: 23963289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T;
    Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
    Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
    Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients.
    Duque AF; Lopez JC; Benitez B; Hernandez H; Yunis JJ; Fernandez W; Arboleda H; Arboleda G
    Colomb Med (Cali); 2015 Sep; 46(3):117-21. PubMed ID: 26600626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LRRK2 mutations in a clinic-based cohort of Parkinson's disease.
    Scholz S; Mandel RJ; Fernandez HH; Foote KD; Rodriguez RL; Barton E; Munson S; Singleton A; Okun MS
    Eur J Neurol; 2006 Dec; 13(12):1298-301. PubMed ID: 17116211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
    Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
    J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lrrk2 R1628P variant is a risk factor for essential tremor.
    Chao YX; Ng EY; Tan L; Prakash KM; Au WL; Zhao Y; Tan EK
    Sci Rep; 2015 Mar; 5():9029. PubMed ID: 25761573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenicity of LRRK2 P755L variant in Parkinson's disease.
    Tan EK; Lim HQ; Yuen Y; Zhao Y
    Mov Disord; 2008 Apr; 23(5):734-6. PubMed ID: 18265005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.
    Carmine Belin A; Westerlund M; Sydow O; Lundströmer K; Håkansson A; Nissbrandt H; Olson L; Galter D
    Mov Disord; 2006 Oct; 21(10):1731-4. PubMed ID: 16817197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
    Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T
    Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
    Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease.
    Bonifati V
    Neurochem Res; 2007 Oct; 32(10):1700-8. PubMed ID: 17440812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
    Pankratz N; Pauciulo MW; Elsaesser VE; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Nichols WC;
    Mov Disord; 2006 Dec; 21(12):2257-60. PubMed ID: 17078063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence.
    Tan EK; Tan LC; Lim HQ; Li R; Tang M; Yih Y; Pavanni R; Prakash KM; Fook-Chong S; Zhao Y
    Hum Genet; 2008 Oct; 124(3):287-8. PubMed ID: 18781329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity.
    Gorostidi A; Ruiz-Martínez J; Lopez de Munain A; Alzualde A; Martí Massó JF
    Neurogenetics; 2009 Apr; 10(2):157-9. PubMed ID: 19020907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population.
    Lu CS; Wu-Chou YH; van Doeselaar M; Simons EJ; Chang HC; Breedveld GJ; Di Fonzo A; Chen RS; Weng YH; Lai SC; Oostra BA; Bonifati V
    Neurogenetics; 2008 Oct; 9(4):271-6. PubMed ID: 18716801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lrrk2 pathogenic substitutions in Parkinson's disease.
    Mata IF; Kachergus JM; Taylor JP; Lincoln S; Aasly J; Lynch T; Hulihan MM; Cobb SA; Wu RM; Lu CS; Lahoz C; Wszolek ZK; Farrer MJ
    Neurogenetics; 2005 Dec; 6(4):171-7. PubMed ID: 16172858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.
    Taylor JP; Hulihan MM; Kachergus JM; Melrose HL; Lincoln SJ; Hinkle KM; Stone JT; Ross OA; Hauser R; Aasly J; Gasser T; Payami H; Wszolek ZK; Farrer MJ
    Neurogenetics; 2007 Apr; 8(2):95-102. PubMed ID: 17225181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.